2002

Berk JL, O’Regan A, Skinner M:
Pulmonary and tracheobronchial amyloidosis. Seminars in Respiratory and Critical Care Medicine, 23:  155-165, 2002.

Lim A, Prokaeva T, Connors LH, Falk RH, Skinner M, Costello CE:
Identification of a novel transthyretin Thr59Lys/Arg104His:  a case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis.  Amyloid: J Protein Folding Disorders, 9: 134-140, 2002.

Lim A, Prokaeva T, McComb ME, O’Connor PB, Theberge R, Connors LH, Skinner M, Costello CE :
Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.  Anal Chem. 74:  741-751, 2002.

Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M:
Low dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.  Brit J Hematology, 117:  886-890, 2002.

Seldin DC:
AL amyloidosis:  A curable disease? editorial in: Amyloid: J Protein Folding Disorders, 9:203-6, 2002.

Sipe JD, Merlini G, Skinner M, Westermark P, Benson M, Kisilevsky R, Bely M:
Meeting Report: IX International Symposium on Amyloidosis, July 15-21, Budapest, Hungary.  Amyloid: The Journal of Protein Folding Disorders, 9: 52-65, 2002.

Yazaki M, Connors LH, Eagle RC, Leff SR, Skinner M, Benson MD:
Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities. Amyloid: J Prot Folding Disorders, 9: 263-267, 2002.

Zerbini CAF, Anderson JJ, Kane KA, Ju S-T, Campistol JM, Simms RW, Cohen AS, Skinner M:
2 microglobulin serum levels and prediction of survival in AL amyloidosis. Amyloid: J Prot Folding Disorders, 9: 242-246, 2002.